Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Preferentially Expressed Antigen in Melanoma (PRAME) (N-Term) Peptide

PRAME Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN982157

Quick Overview for Preferentially Expressed Antigen in Melanoma (PRAME) (N-Term) Peptide (ABIN982157)

Target

PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))

Origin

Human

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-PRAME antibody (Catalog #: ARP55982_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))

    Background

    PRAME functions as a transcriptional repressor, inhibiting the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG. PRAME prevents retinoic acid-induced cell proliferation arrest, differentiation and apoptosis.This gene encodes an antigen that is predominantly expressed in human melanomas and that is recognized by cytolytic T lymphocytes. It is not expressed in normal tissues, except testis. This expression pattern is similar to that of other CT antigens, such as MAGE, BAGE and GAGE. However, unlike these other CT antigens, this gene is also expressed in acute leukemias. Five alternatively spliced transcript variants encoding the same protein have been observed for this gene.

    Alias Symbols: MAPE, OIP4, CT130

    Protein Interaction Partner: STK19,STK19

    Protein Size: 509

    Molecular Weight

    56 kDa

    Gene ID

    23532

    NCBI Accession

    NM_006115, NP_006106

    UniProt

    P78395
You are here:
Chat with us!